The US Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) to ANP Technologies’ NIDS Covid-19 antigen rapid test kit. The test is developed using ANP’s Nano-Intelligent Detection System (NIDS) technology to provide a visual result in 15 minutes from nasal swab specimens. ANP will now focus on the large-scale production of NIDS Covid-19 antigen rapid test kits.
The Indian Council of Medical Research (ICMR) has reportedly assessed a new and faster RT-PCR testing method to detect SARS-CoV-2. According to Times of India, the test does not extract the virus’s genetic RNA before RT-PCR testing to simplify the process. This reduces test time and provides faster results. The alternative method was evaluated with an independent study. The report added that the new method trimmed over-all test turnaround time by two hours with an overall sensitivity of 78.9%.
New research has estimated that around 2.5 million diagnostic diabetes tests were missed or got delayed in the UK during the six-month Covid-19 lockdown last year. According to news reports, the research was presented at the virtual annual meeting of the European Association for the Study of Diabetes (EASD) this week. The figure was extrapolated using data from six laboratory testing centres in the UK. The study further estimated that an additional 1.4 million monitoring tests in people with diabetes were also missed.